An image showing the ARTIC and Pathoplexus logos connected by blue lines, with the text "Hiring: post-doc/software engineer" and "Global open-source pathogen tools" and "Join Swiss TPH, Work on ARTIC2 and Pathoplexus, Basel, Switzerland"

📢New job posting!📢
Are you excited by the idea of building global infrastructure to make pathogen sequencing more accessible, interpretable, and equitable? 🧑🏻‍💻🧬

My group at @swisstph.ch has an opening working with ARTIC2, @pathoplexus.org, & Loculus - read on!

1/5

UShER-TB: Scalable, Comprehensive, Accessible Phylogenomic Analysis of Mycobacterium tuberculosis Mycobacterium tuberculosis, the bacterium responsible for the Tuberculosis (TB) disease, remains a leading global infectious disease killer, and genomic epidemiology is essential for understanding its...

We have team up with @russcd.bsky.social team to bring the fantastic SARS-CoV-2 UShER to TB phylogenomic data. We explore applications in phylogenetics, public health and aDNA among others for de novo phylogenies and for placing samples in a >129K genome phylogeny! 👇
www.medrxiv.org/content/10.1...

Iñaki Comas del @ibv-csic.bsky.social junto a Mariana López y su grupo, ganadores del Premio en la categoría de Transferencia de conocimiento, con mención especial a la candidatura Genómica para políticas públicas: control de pandemias, epidemias y enfermedades del Sur Global
@csic.es
¡Enhorabuena!

🏅 El #CSIC anuncia los ganadores de los II Premios de Transferencia y Emprendimiento

➡️ Los galardones reconocen las actividades del personal investigador y centros e institutos del Consejo para promover estos ámbitos y fomentar la cultura emprendedora

👉 http://tiny.cc/yvlg001

The injustice of tuberculosis Why would John Green, a best-selling American novelist, write a book about tuberculosis? The answer can be found in his new book Everything is Tuberculosis: The History and Persistence of Our Deadlies...

On World Tuberculosis Day, we acknowledge that “tuberculosis is both a form and expression of injustice,” as @johngreensbluesky.bsky.social put it and recommit to ending TB

www.thelancet.com/journals/lan... via @thelancet.bsky.social

Today in the midst of a man-made crisis for science and health we mark #WorldTBDay. The irony is that because of the gem of 🇿🇦🇺🇸🌍 TB science we have better tools than ever and with sustained commitment and funding we coule actually #EndTB. Join us as we discuss the state of TB today at 1pm SAST!

📍Desde el grupo de Demografia del IEGD-CSIC se estudia la evolución histórica de las causas de muerte, en particular la tuberculosis y su interacción con otras enfermedades durante el siglo XIX y XX a través de los registros demográficos👇

🔬El grupo de Química Médica y Biológica Traslacional del CIB-CSIC participa en un proyecto centrado en la búsqueda de candidatos a fármaco para el tratamiento de la tuberculosis ⬇️
https://cib.csic.es/es/departamentos/biomedicina/quimica-medica-y-biologica-traslacional

🧪En el CNB-CSIC se investigan los mecanismos moleculares que limitan la resistencia a los antibióticos en bacterias, especialmente la 'M. tuberculosis'

Entre sus hallazgos, destaca un sistema de corrección de errores en el ADN basado en dos proteínas ⬇️
http://tiny.cc/xk5e001

👩‍🔬En la Unidad de Control de la Regulación Génica en Patógenos del IBV-CSIC, combinan técnicas con análisis bioinformáticos para entender cómo los patógenos microbianos sobreviven y desarrollan resistencia a los antibióticos

👉http://tiny.cc/gm5e001

🔬La Unidad de Genómica de la Tuberculosis del IBV-CSIC se centra en comprender la diversidad genómica y la evolución de la 'M. tuberculosis', bacteria que transmite la enfermedad, para:

➡️Epidemiología
➡️Diagnóstico
➡️Tratamientos
➡️Vacunas

👉https://www.ibv.csic.es/project/genomica-de-la-tuberculosis/

💊Hoy es el #DíaMundialDeLaTuberculosis, la principal causa de muerte por enfermedad infecciosa en el mundo

Equipos del #CSIC y su PTI Salud Global trabajan en romper el círculo vicioso en el que se encuentran esta enfermedad y la pobreza🧵👇

registration back open after a short break - please join us in person if you can!

Statement from WHO TB program on the impact of USAID cuts. TLDR: it's devastating.

hq_globaltuberculosisprogramme.cmail19.com/t/d-e-stuitu...

Our foray in H pylori and drug resistance as part of HpGP consortium. To our surprise very few markers allow to predict clari and levo but emprirical treatments likely compromised. Coled by NIH-NCI Constanza Camargo and @chubordeaux.bsky.social Philippe Lehours
Full👇
papers.ssrn.com/sol3/papers....

TGU Lab from @ibv-csic.bsky.social celebrating science and friendship for Christmas with a petánque tournament

Anita Suresh on LinkedIn: #mutationcatalogue #drugresistance #tuberculosis #seqntreat Closing out 2024 with the TB Mutations Catalogue Experts Group to finalize the strategy and analyses for version 3 of this global resource for predicting drug…

From @mitokondrion.bsky.social : Closing out 2024 with the TB Mutations Catalogue Experts Group to finalize the strategy and analyses for version 3 👇
@FINDdx @who.int

linkedin.com/posts/anitas...

Science4Policy @ibv-csic.bsky.social @csic.es

Yes! The study is an expansion on the original Nat Com paper, all the kudos to Margarida Saraiva as she is the one leading. These are strains strongly associated to mild vs severe TB with consistent immune response signals in different models and human donors